• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Enzon Pharmaceuticals Inc

+ Add to Watchlist

ENZN:US

1.0000 USD 0.0400 3.85%

As of 20:10:00 ET on 04/24/2014.

Snapshot for Enzon Pharmaceuticals Inc (ENZN)

Open: 1.0500 Day's Range: 1.0000 - 1.0700 Volume: 261,804
Previous Close: 1.0400 52wk Range: 0.7800 - 1.5022 1-Yr Rtn: -17.43%

Stock Chart for ENZN

No chart data available.
  • ENZN:US 1.0000
  • 1D
  • 1M
  • 1Y
1.0400
Interactive ENZN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ENZN

Current P/E Ratio (ttm) 2.2183
Estimated P/E(12/2014) -
Relative P/E vs. SPX 0.1288
Earnings Per Share (USD) (ttm) 0.4508
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 44.09
Shares Outstanding (M) 44.09
30 Day Average Volume 523,577
Price/Book (mrq) 8.3893
Price/Sale (ttm) 1.2692
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.4500
Dividend Ex-Date 12/24/2013
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ENZN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ENZN

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company has developed several products, including PEG-INTRON. Enzon's product-focused strategy includes a drug development program that leverages its PEG modification and single-chain antibody (SCA) technologies.

Andrew RackearChief Compliance Ofcr/Secy
More Company Profile & Key Executives for ENZN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil